• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植长期存活者中的高胆固醇血症:加速冠状动脉疾病的早期标志物。

Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease.

作者信息

Eich D, Thompson J A, Ko D J, Hastillo A, Lower R, Katz S, Katz M, Hess M L

机构信息

Medical College of Virginia, Virginia Commonwealth University, Richmond.

出版信息

J Heart Lung Transplant. 1991 Jan-Feb;10(1 Pt 1):45-9.

PMID:2007170
Abstract

Coronary artery disease remains a significant long-term problem for survival after heart transplantation. Hyperlipidemia is a known risk factor for coronary artery disease in the general population, but the role of hyperlipidemia in cardiac allograft recipients has not been elucidated. To study this problem, we retrospectively reviewed 38 heart transplant recipients who survived more than 3 years after surgery and looked at age, development of diabetes, drug protocol, and development of hypercholesterolemia for a possible correlative or predictive value to the development of early coronary artery disease after heart transplantation. Eleven patients were identified as having coronary disease by the third year after transplantation. High-risk cholesterol values (in milligrams per deciliter) at 6 months after heart transplantation were defined as follows: for ages 10 to 20, 190; 20 to 30, 220; 30 to 40, 240; 40+, 260. We found a strong predictive value with high-risk lipid profiles (p less than 0.01) for the development of coronary artery disease by the third year. No significance was found for a low-risk value, the development of diabetes, or hypertension. All patients below the age of 20 years had coronary artery disease by the third year after transplantation. We conclude that a high-risk cholesterol value at 6 months after transplantation is a strong predictor for development of accelerated coronary artery disease and early graft failure. This has major implications for management of hyperlipidemia in the cardiac allograft recipient.

摘要

冠状动脉疾病仍然是心脏移植术后生存面临的一个重大长期问题。高脂血症是一般人群中已知的冠状动脉疾病危险因素,但高脂血症在心脏移植受者中的作用尚未阐明。为研究这一问题,我们回顾性分析了38例术后存活超过3年的心脏移植受者,观察其年龄、糖尿病的发生、药物治疗方案以及高胆固醇血症的发生情况,以探讨其与心脏移植术后早期冠状动脉疾病发生之间可能存在的相关性或预测价值。11例患者在移植后第三年被确诊患有冠状动脉疾病。心脏移植术后6个月时的高危胆固醇值(毫克/分升)定义如下:10至20岁为190;20至30岁为220;30至40岁为240;40岁以上为260。我们发现高危血脂水平对第三年冠状动脉疾病的发生具有很强的预测价值(p小于0.01)。低危值、糖尿病或高血压的发生无显著意义。所有20岁以下的患者在移植后第三年均患有冠状动脉疾病。我们得出结论,移植后6个月时的高危胆固醇值是加速冠状动脉疾病发生和早期移植物功能衰竭的有力预测指标。这对心脏移植受者高脂血症的管理具有重要意义。

相似文献

1
Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease.心脏移植长期存活者中的高胆固醇血症:加速冠状动脉疾病的早期标志物。
J Heart Lung Transplant. 1991 Jan-Feb;10(1 Pt 1):45-9.
2
Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation.心脏移植长期存活者的脂质紊乱与移植后冠状动脉疾病
J Heart Lung Transplant. 1996 Jun;15(6):572-9.
3
The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression.接受低剂量环孢素免疫抑制治疗的心脏移植受者血浆总胆固醇水平升高的决定因素。
J Thorac Cardiovasc Surg. 1992 Aug;104(2):241-7.
4
Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.
Transpl Int. 2007 Aug;20(8):666-74. doi: 10.1111/j.1432-2277.2007.00484.x. Epub 2007 May 23.
5
Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?使用左心室辅助装置过渡到移植是移植冠状动脉疾病的危险因素吗?
J Heart Lung Transplant. 2005 Jun;24(6):703-7. doi: 10.1016/j.healun.2004.03.025.
6
Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.心脏移植后的发病率、功能状态及免疫抑制治疗:国际心肺移植学会/器官共享联合网络胸外科登记处的联合分析
J Heart Lung Transplant. 1998 Apr;17(4):374-82.
7
New-onset cardiovascular risk factors in lung transplant recipients.肺移植受者新发心血管危险因素
J Heart Lung Transplant. 2005 Oct;24(10):1536-43. doi: 10.1016/j.healun.2005.01.004.
8
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.心脏移植后心脏移植血管病变:危险因素与管理
J Heart Lung Transplant. 2004 May;23(5 Suppl):S187-93. doi: 10.1016/j.healun.2004.03.009.
9
Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.小儿心脏移植术后高胆固醇血症很常见:普伐他汀的初步经验。
J Heart Lung Transplant. 2004 Mar;23(3):317-22. doi: 10.1016/S1053-2498(03)00193-1.
10
Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.B型利钠肽升高对预测心脏移植术后移植物功能衰竭、心脏移植血管病变及生存率的价值。
Am J Cardiol. 2004 Aug 15;94(4):454-8. doi: 10.1016/j.amjcard.2004.04.060.

引用本文的文献

1
Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients.心脏移植患者家族性高胆固醇血症的机会性基因筛查
J Clin Med. 2023 Feb 3;12(3):1233. doi: 10.3390/jcm12031233.
2
Cardiac allograft vasculopathy: current review and future research directions.心脏移植后血管病:当前综述与未来研究方向。
Cardiovasc Res. 2021 Nov 22;117(13):2624-2638. doi: 10.1093/cvr/cvab259.
3
Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.心脏移植后的移植血管病:他汀类药物治疗作用的系统评价
World J Surg. 2014 Sep;38(9):2324-34. doi: 10.1007/s00268-014-2543-x.
4
Endothelial dysfunction and cardiac allograft vasculopathy.内皮功能障碍与心脏同种异体移植物血管病。
J Cardiovasc Transl Res. 2013 Apr;6(2):263-77. doi: 10.1007/s12265-012-9414-3. Epub 2012 Nov 8.
5
Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.炎症性 Ly-6C(hi) 单核细胞在高脂血症受者严重移植性动脉硬化的发展中起重要作用。
Atherosclerosis. 2012 Aug;223(2):291-8. doi: 10.1016/j.atherosclerosis.2012.05.010. Epub 2012 May 19.
6
First-year clinical outcomes in gender-mismatched heart transplant recipients.性别错配心脏移植受者的 1 年临床结局。
J Cardiovasc Nurs. 2012 Nov-Dec;27(6):519-27. doi: 10.1097/JCN.0b013e31822ce6c9.
7
Acceleration of allograft failure by cytomegalovirus.巨细胞病毒加速同种异体移植失败。
Curr Opin Immunol. 2007 Oct;19(5):577-82. doi: 10.1016/j.coi.2007.07.012. Epub 2007 Aug 22.
8
The metabolic effects of cyclosporin and tacrolimus.
J Endocrinol Invest. 2000 Jul-Aug;23(7):482-90. doi: 10.1007/BF03343761.
9
Simvastatin after orthotopic heart transplantation. Costs and consequences.
Pharmacoeconomics. 1999 Mar;15(3):279-89. doi: 10.2165/00019053-199915030-00007.
10
Accelerated graft atherosclerosis after heart transplantation.心脏移植后加速性移植血管动脉粥样硬化
Br Heart J. 1993 May;69(5):469-70. doi: 10.1136/hrt.69.5.469-a.